Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Petites Cellules is a boutique strategic consulting firm specializing in oncology drug development and clinical research strategy. The company provides high-level advisory services to biotechnology and pharmaceutical firms, focusing on clinical trial design, regulatory interactions, and portfolio optimization. Founded by Dr. Jean-Pierre Bizzari, a renowned expert in oncology and former executive at Celgene and Sanofi-Aventis, the group leverages deep industry knowledge to guide clients through the complexities of cancer therapy development. Petites Cellules assists organizations in navigating the path from pre-clinical research to global commercialization, ensuring that innovative treatments are developed efficiently. The firm is highly regarded for its expertise in hematology and solid tumor indications. Its strategic insights help bridge the gap between scientific discovery and clinical success for emerging biotech companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Petites Cellules.